March 23, 2018

March 23, 2018

Cases of rare cancer linked to breast implants on the rise

Today Online – March 22

Boone underwent four six-week rounds of chemotherapy, plus a stem cell transplant at Moffitt Cancer Center in Tampa, Florida. Both of her breast implants were removed. She says she came close to dying before things turned around. She'll be three years in remission in June. 

Florida lawmakers split on spending package

Tampa Bay Times – March 22

The omnibus appropriations bill invests boldly in Tampa Bay area economic engines, including Moffitt Cancer Center, University of South Florida, Tampa International Airport and our Port. 

More Cases Reported of New Cancer Associated with Textured Breast Implants

CMR News – March 23

Her diagnosis: breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a type of non-Hodgkin’s lymphoma.  Boone underwent four six-week rounds of chemotherapy, plus a stem cell transplant at Moffitt Cancer Center in Tampa, Florida. Both of her breast implants were removed. 

Helix BioPharma Corp Welcomes Drs. Daniel Von Hoff, Kazimierz Roszkowski-Sliz and Robert Gillies to Its Scientific and Strategic Advisory Board

The News Reports – March 22

Dr. Robert Gillies holds the Martin Silbiger Endowed Chair and is Chair of the Department of Cancer Physiology and Vice-Chair (Research) of the Department of Radiology, H. Lee Moffitt Cancer Center and Research Institute; and Professor Emeritus, Departments of Radiology and Biomedical Engineering, College of Medicine, University of Arizona. 

Adjuvant Immunotherapy in Advanced Melanoma

Cancer Network – March 22

Dr. Weber: Yes, back when I was at the Moffitt Cancer Center in Tampa, I initiated a pilot trial that was initially 20 patients, who got the combination of ipilimumab and nivolumab. They had stage IIIC and stage IV resected melanoma, which we think of as the bad actors at the highest risk of relapse.  

IRONMAN Expansion to Create 70 New Jobs at Tampa Headquarters

Florida Trend – March 22

Alan F. List, MD, chairman of the Tampa Hillsborough Economic Development Corporation and president and CEO of Moffitt Cancer Center, said, “IRONMAN is another prime example of a locally headquartered company with a global reputation whose success is helping to shape Tampa’s economic future. The strength and diversity of our corporate headquarters are attracting more world-class companies and talent to Hillsborough County each year.” 

This DNA-Based Attack Against Cancer May Just Work
Smithsonian Magazine – March 22

One of his lymph nodes had swollen to the size of a golf ball—his cancer was back for the third time, and all his therapy options were exhausted. Or so he thought until he met Frederick Locke, an oncologist who leads the immune cell therapy initiative at Moffitt Cancer Center in Tampa. 

HPV is causing an oral cancer epidemic in men by outwitting natural defenses

Chicago Tribune – March 21

Anna R. Giuliano, the researcher at the Moffitt Cancer Center in Tampa, Fla., who led the HIM study, said recurring infections may be due to reactivation of dormant virus, or to auto-inoculation the man spreads infection from one part of his body to another. Or to something else entirely. 

Gov. Scott: IRONMAN Expansion to Create 70 New Jobs at Tampa Headquarters

Capital Soup – March 21

Alan F. List, MD, chairman of the Tampa Hillsborough Economic Development Corporation and president and CEO of Moffitt Cancer Center, said, “IRONMAN is another prime example of a locally headquartered company with a global reputation whose success is helping to shape Tampa’s economic future. The strength and diversity of our corporate headquarters are attracting more world-class companies and talent to Hillsborough County each year.” 

Curbing Abuse in the OR: Anesthesiology News Report

MedPage Today – March 21

A research team at Moffitt Cancer Center in Tampa, FL, reported the results of a cost-effectiveness analysis at their institution comparing awake and asleep craniotomy techniques. 

More Cases of Severe Myocarditis Linked to Immunotherapy

Medscape – March 21

When asked to comment, Michael Fradley, MD, director of the joint Cardio-Oncology Program at the University of South Florida and the Moffitt Cancer Center in Tampa, emphasized that this report should not cause clinicians to abandon a highly effective cancer treatment. 

Approaching Treatment for Relapsed/Refractory ALL

OncLive – March 21

Bijal D. Shah, MD: I’ve certainly tried giving it to patients who were still receiving their TAC (tacrolimus) and their RAPA (sirolimus), which is what we use as our GvH prophylaxis without much success.

Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance

Oncology Nurse Advisor – March 20

Brian D. Gonzalez, PhD, of the Department of Health Outcomes and Behavior at Moffitt Cancer Center in Tampa, Florida, and colleagues compared 78 men with PCa who were placed on ADT with matched groups of 99 men with PCa who underwent radical prostatectomy but not placed on ADT and 108 men with no history of cancer. 

Novartis taps Harvard tech to advance cancer immunotherapy efforts

BioPharma Dive – March 20

Although Novartis did not respond to an inquiry about what targets they plan to pursue in combination with Harvard's engineered asset, and what investigational agents it might pair with the biomaterial, it is already conducting a trial examining autologous tumor vaccine in mantle cell lymphoma with the H. Lee Moffitt Cancer Center and Research Institute.

Deciding on SSA Treatment in NETs

OncLive – March 20

Heloisa P. Soares, MD: It’s a very interesting and deep discussion with patients, in terms of how we’re going to decide when to start treatment and how to start treatment. Patients that have a very functional tumor are secreting hormones that you probably want to control.

Pharmacogenomics in practice

APhA – March 15

Drug information and literature evaluation skills are crucial for potential links between a medication and the gene of interest. I also had the opportunity to sit in on the discussions of the Personalized Cancer Medicine Service at Moffitt Cancer Center. The 
discussions center around finding molecularly targeted therapies for somatic mutations identified from a tumor biopsy.


Will removing your fallopian tubes reduce your risk of ovarian cancer?

Harvard Health Publishing – April 2018

"It turns out that ovarian cancer is a bit of a misnomer. We think a portion of ovarian cancers actually arise from cells in the fallopian tubes," says Shelley Tworoger, adjunct associate professor of epidemiology at Harvard Medical School and associate center director of population science at the Moffitt Cancer Center.

Telomerase: Update and Downgrade

Josh Mitteldorf – March 19

In this study from the Moffitt Cancer Center, short telomeres (as measured directly, not imputed from genetic variation) are associated with higher risk of squamous cell skin cancer, but long telomeres are associated with higher risk of melanoma skin cancer. 

Investigating CAR T-Cell Therapy in Patients With DLBCL, FL, and Other Lymphomas

Cancer Network – March 7

Cancer Network recently had an opportunity to speak with Frederick Locke, MD, a medical oncologist and translational researcher at Moffitt Cancer in Tampa, Florida, who specializes in stem cell transplantation and cell-based therapies for hematologic malignancies. 

Job fairs help connect people to open jobs in healthcare, many other professions

83 Degrees Media – March 20

Longo’s background is in healthcare -- and she noticed the need for employees in the field at a recent job fair, when Tampa’s Moffitt Cancer Center gave her a list of some 400 openings. “That’s a lot of openings,” says Longo. “We couldn’t even begin to list them.”

MRD-Positive ALL: Personal Approaches to Treatment

OncLive – March 19

Bijal D. Shah, MD: I’m glad you hit on that, because I think it ties in nicely to the concept of T-cell ALL. We’ve been very focused on B-cell ALL. 

Hillsborough County's top attorney will resign

Tampa Bay Business Journal – March 19

Hillsborough County attorney Charles "Chip" Fletcher is stepping down after nearly five and half years in that role to become vice president, deputy general counsel at H. Lee Moffitt Cancer Center and Research Institute.

Short-staffed and confined to old buildings, USF cops try to keep up. ‘I spend most of my time begging’

Tampa Bay Times – March 19

At USF, the state ratio doesn’t account for Sun Dome visitors, staff at Moffitt Cancer Center or the department’s 1,000-foot perimeter full of student apartments. Even 73 officers might not be the right number, USF board chairman Brian Lamb said last month.

Moffitt Healthy Kidz seeks high school seniors for scholarship program

Tampa Bay Times – March 16

The Moffitt Healthy Kidz program at Tampa’s Moffitt Cancer Center is currently accepting submissions for their annual Role Model Scholarship.

Hundreds of men receive free screenings at health forum

Bay  News 9 – March 17

On Saturday, hundreds of men took advantage of free screenings and services at Moffitt Cancer Center’s annual Men’s Health Forum.

Scott Signs Budget, Takes It Easy On Vetoes

WUSF – March 17

The University of South Florida had four projects vetoed - three at the St. Petersburg campus and one at Sarasota-Manatee. The Coalition for Medicinal Cannabis Research in Moffitt Cancer Center received a $150,000 veto.

Vetoed: These Tampa Bay projects got cut by the governor

Tampa Bay Times – March 17

  • Coalition for Medicinal Cannabis Research in Moffitt Cancer Center: $150,000

Aspiring environmental engineer and doctor named Thiel College 2018 March Students of the Month

Theil College – March 17

During the summer of 2017, she completed a clinical research and shadowing internship at the University of South Florida and Moffitt Cancer Center.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.